OOIR: Observatory of International Research

Papers

(The H4-Index of Brain is 75. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings	809
Brain-first versus body-first Parkinson’s disease: a multimodal imaging case-control study	398
Microglial exosomes facilitate α-synuclein transmission in Parkinson’s disease	252
COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital	243
Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19	237
Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model	224
Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification	216
Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description	210
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome	203
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease	193
MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide	184
Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state	169
Phosphorylated tau interactome in the human Alzheimer’s disease brain	168
Post-stroke deficit prediction from lesion and indirect structural and functional disconnection	165
Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study	165
Medial temporal lobe connectivity and its associations with cognition in early Alzheimer’s disease	161
Neurofilaments: neurobiological foundations for biomarker applications	161
Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease	148
Sleep deprivation impairs molecular clearance from the human brain	145
Definitions and classification of malformations of cortical development: practical guidelines	144
18F-MK-6240 PET for early and late detection of neurofibrillary tangles	143
Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates	135
Alzheimer’s disease brain-derived extracellular vesicles spread tau pathology in interneurons	130
Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions	129
How patients with multiple sclerosis acquire disability	128

CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease	126
Time course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum	125
Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI	123
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer’s disease	120
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options	120
CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson’s disease	118
Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures	116
Neurovascular injury with complement activation and inflammation in COVID-19	113
White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA-Epilepsy study	113
Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis	109
Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes	109
Microglial activation and tau burden predict cognitive decline in Alzheimer’s disease	107
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease	106
Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism	104
Comorbid neuropathological diagnoses in early versus late-onset Alzheimer’s disease	100
Relationship between cortical iron and tau aggregation in Alzheimer’s disease	100
Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease	99
18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseases	98
The role of genetics in Parkinson’s disease: a large cohort study in Chinese mainland population	97
The potential of serum neurofilament as biomarker for multiple sclerosis	97
Emerging roles for dynamic aquaporin-4 subcellular relocalization in CNS water homeostasis	96
Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex	95
Acute and non-resolving inflammation associate with oxidative injury after human spinal cord injury	95
Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes	92
Genetic variants and functional pathways associated with resilience to Alzheimer’s disease	91
Hearing and dementia: from ears to brain	90
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder	90
To what degree is late life cognitive decline driven by age-related neuropathologies?	90
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients	89
Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics	87
Natural history of motor symptoms in Parkinson’s disease and the long-duration response to levodopa	87
Detection of neuron-derived pathological α-synuclein in blood	85
Functional cognitive disorder: dementia’s blind spot	85
CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer’s disease	84
Depression, dementia and immune dysregulation	81
Developmental and epileptic encephalopathies: what we do and do not know	81
Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis	81
The GGC repeat expansion inNOTCH2NLCis associated with oculopharyngodistal myopathy type 3	80
An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas	79
Early stages of tau pathology and its associations with functional connectivity, atrophy and memory	79
The synapse in traumatic brain injury	78
Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management	78
Studying human nociceptors: from fundamentals to clinic	78
A clinical-radiological framework of the right temporal variant of frontotemporal dementia	77
The role of noradrenaline in cognition and cognitive disorders	77
Predicting future rates of tau accumulation on PET	76
The development and convergence of co-pathologies in Alzheimer’s disease	76
Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy	75
COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations	75
Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability	75